Evaluation of a urine on-site drugs of abuse screening test in patients admitted to a psychiatric emergency unit

Journal of Clinical Psychopharmacology

Volumn 29, Issue 3, 2009, Pages 248-254

  Bagøien, Gunnhild ^a,b   Morken, Gunnar ^a,b   Zahlsen, Kolbjørn ^a   Aamo, Trond ^a   Spigset, Olav ^a,b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

On site urine drug screening test; Psychiatric emergency unit; Substance abuse

Indexed keywords

AMPHETAMINE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABIS; COCAINE; OPIATE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANNABIS ADDICTION; COCAINE DEPENDENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG ABUSE; DRUG DEPENDENCE; EMERGENCY WARD; FEMALE; HUMAN; LABORATORY TEST; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MEDICAL ASSESSMENT; OPIATE ADDICTION; PRIORITY JOURNAL; PSYCHIATRIC DEPARTMENT; SCREENING TEST; SENSITIVITY AND SPECIFICITY; URINALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHROMATOGRAPHY, LIQUID; EMERGENCY SERVICES, PSYCHIATRIC; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STREET DRUGS; SUBSTANCE ABUSE DETECTION; URINALYSIS; YOUNG ADULT;

EID: 67649280492     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181a45e78     Document Type: Article

References (32)

1. Drake RE, Wallach MA. Substance abuse among the chronic mentally ill. Hosp Community Psychiatry. 1989;40:1041-1046.
2. Swofford CD, Kasckow JW, Scheller-Gilkey G, et al. Substance abuse: a powerful predictor of relapse in schizophrenia. Schizophr Res. 1996;20:145-151.
3. Breslow RE, Klinger BI, Erickson BJ. Acute intoxication and substance abuse among patients presenting to a psychiatric emergency service. Gen Hosp Psychiatry. 1996;18:183-191.
4. Tardiff K, Marzuk PM, Leon AC, et al. Violence by patients admitted to a private psychiatric hospital. Am J Psychiatry. 1997;154:88-93.
5. Scott H, Johnson S, Menazes P, et al. Substance misuse and risk of aggression and offending among severely mentally ill. Br J Psychiatry. 1998;172:345-350.
6. Zealberg JJ, Brady KT. Substance abuse and emergency psychiatry. Psychiatr Clin North Am. 1999;22:803-817.
7. Soyka M. Substance misuse, psychiatric disorder and violent and disturbed behavior. Br J Psychiatry. 2000;176:345-350.
8. Caton CL, Drake RE, Hasin DS, et al. Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induces psychoses. Arch Gen Psychiatry. 2005;62:137-145.
9. Vaaler AE, Morken G, FlLvig JC, et al. Substance use and recovery in a psychiatric intensive care unit. Gen Hosp Psychiatry. 2006;28:65-70.
10. Anath J, Vandewater S, Kamal M, et al. Missed diagnosis of substance abuse in psychiatric patients. Hosp Community Psychiatry. 1989;40:297-299.
11. Szuster RR, Schanbacher BL, McCann SC, et al. Underdiagnosis of psychoactive-substance-induced organic mental disorders in emergency psychiatry. Am J Drug Alcohol Abuse. 1990;16:319-327.
12. Elangovan N, Berman S, Meizner A, et al. Substance abuse among patients presenting at an inner-city psychiatric emergency room. Hosp Community Psychiatry. 1993;44:782-784.
13. Hansen SS, Munk-JLrgensen P, Guldb&k B, et al. Psychoactive substance use diagnoses among psychiatric in-patients. Acta Psychiatr Scand. 2000;102:432-438.
14. Lehman AF, Myers CP, Corty E, et al. Prevalence and patterns of Bdual diagnosis[ among psychiatric in-patients. Compr Psychiatry. 1994;35:106-112.
15. Mordal J, Bramness JG, Holm B, et al. Drugs of abuse among psychiatric and medical admissions: laboratory based identification of prevalence and drug influence. Gen Hosp Psychiatry. 2008;30:55-60.
16. O'Mathúna B, Farré M, Rostami-Hodjegan A, et al. The consequences of 3,4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans. J Clin Psychopharmacol. 2008;28:525-531.
17. Claassen CA, Gilfillan S, Orsulak P, et al. Substance use among patients with a psychotic disorder in a psychiatric emergency room. Psychiatr Serv. 1997;48:353-358.
18. Schiller MJ, Shumway M, Batki SL. Utility of routine drug screening in a psychiatric emergency setting. Psychiatr Serv. 2000;51:474-478.
19. Taylor EH, Oertli EH, Wolfgang JW. Accuracy of five on-site immunoassay drugs-of-abuse testing devices. J Anal Toxicol. 1999;23:119-124.
20. Peace MR, Tarnai LD, Poklis A. Performance evaluation of four on-site drug-testing devices for detection of drugs of abuse in urine. J Anal Toxicol. 2000;24:589-594.
21. Buchan BJ, Walsh JM, Leaverton PE. Evaluation of the accuracy of on-site multi-analyte drug testing devices in the determination of the prevalence of illicit drugs in drivers. J Forensic Sci. 1998;43:295-299.
22. Leino A, Saarinmies J, Grönholm M, et al. Comparison of eight commercial on-site screening devices for drugs-of-abuse testing. Scand J Clin Lab Invest. 2001;61:325-332.
23. Crouch DJ, Hersch RK, Cook RF, et al. A field evaluation of five on-site drug-testing devices. J Anal Toxicol. 2002;26:493-499.
24. Grönholm M, Lillsunde P. A comparison between on-site immunoassay drug-testing devices and laboratory results. Forensic Sci Int. 2001;121:37-42.
25. Ferrara SD, Tedeschi L, Frison G, et al. Drugs-of-abuse testing in urine: statistical approach and experimental comparison of immunochemical and chromatographic techniques. J Anal Toxicol. 1994;18:278-291.
26. Peace MR, Poklis JL, Tarnai LD, et al. An evaluation of the OnTrak Testcup-er on-site urine drug-testing device for drugs commonly encountered from emergency departments. J Anal Toxicol. 2002;26:500-503.
27. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva, Switzerland: World Health Organization; 1993.
28. Princeton BioMeditech Corporation. AccuSign DOA 5 User Manual. Rev ed. Princeton, NJ: Princeton BioMeditech Corporation; 2003.
29. Divoll MK, Greenblatt DJ. The admissibility of positive EMIT results as scientific evidence: counting facts, not heads. J Clin Psychopharmacol. 1985;5:114-116.
30. Greenblatt DJ, Shader RI. Say Bno[ to drug testing. J Clin Psychopharmacol. 1990;10:157-159.
31. Department of Health and Human Services, Substance Abuse and Mental Health Administration. Mandatory guidelines and proposed revisions to mandatory guidelines for federal workplace drug testing programs. Fed Regist. 2004;69:19644-19673.
32. Schiller MJ, Shumway M, Batki SL. Patterns of substance use among patients in an urban psychiatric emergency service. Psychiatr Serv. 2000;51:113-115.